Gastroenterology and Hepatology from Bed to Bench

Vol. 16 No. 2 (2023)

Is Irritable Bowel Syndrome out of date and misleading as a diagnosis? Lifestyle, Gluten and Lactose are the major culprits

Gastroenterology and Hepatology from Bed to Bench, Vol. 16 No. 2 (2023), 21 April 2023
https://doi.org/10.22037/ghfbb.v16i2.2761

Abstract

Aim: This study aimed at assessing the efficacy of targeted interventions addressing common food sensitivities and lifestyle factors that commonly contribute to the presentation of gastrointestinal problems identified as Irritable bowel syndrome (IBS).

Background: IBS has served to cover the expression of multifactorial disorders with variable aetiology and pathophysiology. Food antigens implicated in the modern lifestyle, acting as strong epigenetic factors is strongly implicated in pathophysiology of conditions under IBS. Identifying and addressing food sensitivities in patients presenting with IBS like symptoms are currently underemphasised in clinical guidelines yet have the potential to provide major benefits for patients.  

Methods: Information was collected from the medical records of patients that were referred to the Gastroenterology Unit of Palmerston North DHB with unexplained gastrointestinal (GI) symptoms with or without other GI comorbidities between September 2018 and November 2021.

Results: The main management option offered to the 121 patients included in this study, was lifestyle adjustment and/or a trial of 6 weeks, eliminating gluten and lactose from the diet. The most prevalent symptoms were abdominal pain 96/121 (79%), diarrhoea 83/121 (69%), followed by bloating and constipation. Seventy-eight patients had the outcomes of their improvement available. A total of 42 out of 78 patients (54%) were treated exclusively with gluten and lactose-free diet, in this group of patients 86% (36/42) reported a significant improvement in their symptoms with a score in the range of 40-100%.

Conclusion: Our study illustrates the importance of focusing on triggering factors when assessing patients with IBS. We suggest that careful identifying and eliminating the triggering food antigens as monotherapy or in addition to the lifestyle adjustment where appropriate should be the main objective in symptomatic patients fulfilling the IBS diagnostic criteria. These combinations and holistic approach in treating IBS’ patients’ symptoms are less expensive, non-toxic, and highly effective in achieving optimal outcomes and improving these patient’s quality of life.

Keywords:
  • IBS
  • Gluten
  • non-coeliac gluten sensitivity
  • lactose intorelance

How to Cite

Sua, T., Montoya, C. ., Luo, D. ., & Rostami, K. . (2023). Is Irritable Bowel Syndrome out of date and misleading as a diagnosis? : Lifestyle, Gluten and Lactose are the major culprits. Gastroenterology and Hepatology from Bed to Bench, 16(2). https://doi.org/10.22037/ghfbb.v16i2.2761

References

1. Whitcomb Jr FF, Cain JC. Irritable bowel. Postgraduate Medicine 1963;33(3):233-236.
2. Rostami K, Ensari A, Marsh MN, et al. Gluten induces subtle histological changes in duodenal mucosa of patients with non-coeliac gluten sensitivity: a multicentre study. Nutrients 2022;14(12):2487.
3. Schuppan D, Gisbert-Schuppan K. ATI sensitivity. Wheat Syndromes: Springer; 2019:57-91.
4. Lomer MC, Parkes G, Sanderson J. lactose intolerance in clinical practice–myths and realities. Alimentary pharmacology & therapeutics 2008;27(2):93-103.
5. Blomhoff S, Diseth TH, Jacobsen MB, Vatn M. [Irritable bowel syndrome--a multifactorial disease in children and adults]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 2002;122(12):1213-1217. (In nor) (http://europepmc.org/abstract/MED/12089850).
6. Dupont H. evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets. Alimentary pharmacology & therapeutics 2014;39(10):1033-1042.
7. Watson B. What is IBS? 1964.
8. Shahbazkhani B, Sadeghi A, Malekzadeh R, et al. Non-celiac gluten sensitivity has narrowed the spectrum of irritable bowel syndrome: a double-blind randomized placebo-controlled trial. Nutrients 2015;7(6):4542-4554.
9. Xiong L, Wang Y, Gong X, Chen M. Prevalence of lactose intolerance in patients with diarrhea-predominant irritable bowel syndrome: data from a tertiary center in southern China. Journal of Health, Population and Nutrition 2017;36(1):1-5.
10. Vasant DH, Paine PA, Black CJ, et al. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut 2021;70(7):1214-1240.
11. Soubieres A, Wilson P, Poullis A, Wilkins J, Rance M. Burden of irritable bowel syndrome in an increasingly cost-aware National Health Service. Frontline Gastroenterol 2015;6(4):246-251. (In eng). DOI: 10.1136/flgastro-2014-100542.
12. Rostami K, Bold J, Ali JI, et al. An algorithm for differentiating food antigen-related gastrointestinal symptoms. Gastroenterology and Hepatology from Bed to Bench 2021;14(1):8.
13. Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. Br Med J 1978;2(6138):653-4. (In eng). DOI: 10.1136/bmj.2.6138.653.
14. Lembo A. Irritable bowel syndrome medications side effects survey. Journal of clinical gastroenterology 2004;38(9):776-781.
15. Sanders D. Irritable bowel syndrome and coeliac disease. The Lancet 2002;359(9315):1436-1437.
16. Karling P, Danielsson Å, Adolfsson R, Norrback Kf. No difference in symptoms of irritable bowel syndrome between healthy subjects and patients with recurrent depression in remission. Neurogastroenterology & Motility 2007;19(11):896-904.
17. Lacy BE, Everhart KK, Weiser KT, et al. IBS patients' willingness to take risks with medications. Official journal of the American College of Gastroenterology| ACG 2012;107(6):804-809.
18. Catassi C, Elli L, Bonaz B, et al. Diagnosis of non-celiac gluten sensitivity (NCGS): the Salerno experts’ criteria. Nutrients 2015;7(6):4966-4977.
19. Krassowski M. ComplexUpset: Create complex UpSet plots using ggplot2 components. R package version 05 2020;18.
20. Team RDC. A language and environment for statistical computing. http://www R-project org 2009.
21. Storhaug CL, Fosse SK, Fadnes LT. Country, regional, and global estimates for lactose malabsorption in adults: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology 2017;2(10):738-746.
22. Rosado JL. Intolerancia a la lactosa. Gac Med Mex 2016;152(Supl 1):67-73.
23. Montes P, Monge E. Lactose malabsorption and IBS. Scandinavian journal of gastroenterology 2004;39(10):1033-1033.
24. Fasano A, Sapone A, Zevallos V, Schuppan D. Nonceliac gluten sensitivity. Gastroenterology 2015;148(6):1195-1204.
25. Sapone A, Bai JC, Ciacci C, et al. Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC medicine 2012;10(1):1-12.
26. Holmes G. Non coeliac gluten sensitivity. Gastroenterol Hepatol Bed Bench 2013;6(3):115-9. (In eng).
27. Palsson OS, Whitehead WE, Van Tilburg M, et al. Rome IV diagnostic questionnaires and tables for investigators and clinicians. Gastroenterology 2016:S0016-5085 (16) 00180.
28. Vasant DH, Paine PA, Black CJ, et al. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut 2021;70(7):1214-1240. DOI: 10.1136/gutjnl-2021-324598.
29. Drossman DA. Irritable bowel syndrome: A multifactorial disorder. Hospital Practice 1988;23(9):119-133.
30. Occhipinti K, Smith JW. Irritable bowel syndrome: a review and update. Clinics in colon and rectal surgery 2012;25(01):046-052.
31. Adriani A, Ribaldone DG, Astegiano M, Durazzo M, Saracco GM, Pellicano R. Irritable bowel syndrome: the clinical approach. Panminerva medica 2018;60(4):213-222. (In eng). DOI: 10.23736/s0031-0808.18.03541-3.
  • Abstract Viewed: 165 times
  • PDF Downloaded: 131 times

Download Statastics

Developed By

Open Journal Systems